Trades on 1 secondary market
Gate Bioscience
Gate Bioscience is a preclinical biotechnology company founded in 2021 and headquartered in Brisbane, California, creating a new class of small-molecule medicines called Molecular Gates. Molecular Gates selectively eliminate disease-causing extracellular proteins at their origin inside the cell by b
Gate Bioscience is an API provider whose private shares are listed on 1 secondary market: EquityZen.
Where It Trades
Listing data is compiled from the public marketplace pages of Forge Global, Hiive, EquityZen, Nasdaq Private Market, and Augment. A listing indicates that a venue has published a page for this company — it is not an offer, a quote, or investment advice, and APIs.io has no affiliation with any venue.